Healthcare provider profile · identity verified

Ataur Rehman, M.D.

Internal Medicine · ANNISTON, AL · NPI 1770764201

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	486	139
Gabapentin	Gabapentin	432	87
Amlodipine Besylate	Amlodipine Besylate	355	100
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	330	61
Rosuvastatin Calcium	Rosuvastatin Calcium	302	80
Metformin Hcl	Metformin Hcl	293	83
Levothyroxine Sodium	Levothyroxine Sodium	273	80
Omeprazole	Omeprazole	243	67
Lisinopril	Lisinopril	242	74
Pantoprazole Sodium	Pantoprazole Sodium	233	72
Carvedilol	Carvedilol	197	59
Furosemide	Furosemide	188	58
Meloxicam	Meloxicam	177	49
Losartan Potassium	Losartan Potassium	168	56
Citalopram Hbr	Citalopram Hydrobromide	162	36
Azithromycin	Azithromycin	161	119
Jardiance	Empagliflozin	153	32
Montelukast Sodium	Montelukast Sodium	151	44
Clopidogrel	Clopidogrel Bisulfate	150	46
Famotidine	Famotidine	135	49
Valsartan	Valsartan	130	43
Potassium Chloride	Potassium Chloride	126	35
Duloxetine Hcl	Duloxetine Hcl	121	27
Tamsulosin Hcl	Tamsulosin Hcl	117	34
Prednisone	Prednisone	116	73
Trazodone Hcl	Trazodone Hcl	111	21
Allopurinol	Allopurinol	110	33
Metoprolol Tartrate	Metoprolol Tartrate	105	32
Mirtazapine	Mirtazapine	105	26
Sertraline Hcl	Sertraline Hcl	103	23
Albuterol Sulfate Hfa	Albuterol Sulfate	101	36
Eliquis	Apixaban	90	21
Methocarbamol	Methocarbamol	90	33
Tizanidine Hcl	Tizanidine Hcl	89	18
Simvastatin	Simvastatin	87	26
Zolpidem Tartrate	Zolpidem Tartrate	86	suppressed
Ozempic	Semaglutide	84	14
Cephalexin	Cephalexin	83	53
Metoprolol Succinate	Metoprolol Succinate	83	26
Hydrochlorothiazide	Hydrochlorothiazide	82	25
Fluticasone Propionate	Fluticasone Propionate	80	35
Escitalopram Oxalate	Escitalopram Oxalate	77	21
Tramadol Hcl	Tramadol Hcl	74	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	16
Clonazepam	Clonazepam	67	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	16
Ropinirole Hcl	Ropinirole Hcl	65	12
Atenolol	Atenolol	63	20
Pravastatin Sodium	Pravastatin Sodium	60	19
Irbesartan	Irbesartan	57	16
Triamcinolone Acetonide	Triamcinolone Acetonide	56	39
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	54	21
Diltiazem Hcl	Diltiazem Hcl	51	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	51	12
Ondansetron Hcl	Ondansetron Hcl	51	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	51	12
Ibuprofen	Ibuprofen	50	20
Memantine Hcl	Memantine Hcl	45	suppressed
Glipizide	Glipizide	42	11
Warfarin Sodium	Warfarin Sodium	42	suppressed
Farxiga	Dapagliflozin Propanediol	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Alprazolam	Alprazolam	39	suppressed
Clonidine Hcl	Clonidine Hcl	37	11
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	13
Cefdinir	Cefdinir	35	31
Pregabalin	Pregabalin	35	suppressed
Temazepam	Temazepam	35	13
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	13
Lovastatin	Lovastatin	34	suppressed
Sucralfate	Sucralfate	34	19
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	30
Finasteride	Finasteride	30	suppressed
Baclofen	Baclofen	29	suppressed
Carisoprodol	Carisoprodol	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	13
Trulicity	Dulaglutide	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Topiramate	Topiramate	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	11
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Nystatin	Nystatin	24	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Linzess	Linaclotide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Ramipril	Ramipril	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fluconazole	Fluconazole	18	15
Loperamide	Loperamide Hcl	18	11
Ranolazine Er	Ranolazine	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Trintellix	Vortioxetine Hydrobromide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	15
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Minocycline Hcl	Minocycline Hcl	14	13
Olanzapine	Olanzapine	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	11
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Promethazine Hcl	Promethazine Hcl	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Bidil	Isosorbide Dinit/Hydralazine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Lexapro	Escitalopram Oxalate	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error